Sarepta Therapeutics, Inc. — Director's Dealing 2012

Apr 25, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AVI BIOPHARMA INC (AVII)
CIK: 0000873303
Period of Report: 2012-04-24

Reporting Person: JACOBSEN MICHAEL A (VP of Finance and PAO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-04-24	Stock Option (right to buy)	$0.9	A	22211	Acquired	2022-04-24	Common Stock (22211)	Direct

Footnotes

F1: This option is exercisable at the rate of 25% of the shares on April 24, 2013 and 1/48th of the total granted shares on each monthly anniversary thereafter, such that the option will be fully exercisable on April 24, 2016.